Article

The prevalence of primary angle closure glaucoma in European derived populations: a systematic review

UCL Institute of Ophthalmology, 11-43 Bath Street, London EC1V 9EL, UK
The British journal of ophthalmology (Impact Factor: 2.81). 05/2012; 96(9):1162-7. DOI: 10.1136/bjophthalmol-2011-301189
Source: PubMed

ABSTRACT To estimate the prevalence of primary angle closure glaucoma (PACG) in European derived populations.
Systematic review and modelling of PACG prevalence data from population studies. PACG was defined according to the ISGEO definition requiring structural and/or functional evidence of glaucomatous optic neuropathy. Prevalence estimates were applied to the 2010 United Nations projected population figures to estimate case numbers.
The prevalence of PACG in those 40 years or more is 0.4% (95% CI 0.3% to 0.5%). Age-specific prevalence values are 0.02% (CI 0.00 to 0.08) for those 40-49 years, 0.60% (0.27 to 1.00) for those 50-59 years, 0.20% (0.06 to 0.42) for those 60-69 years and 0.94% (0.63 to 1.35) for those 70 years and older. Three-quarters of all cases occur in female subjects (3.25 female to 1 male; CI 1.76 to 5.94).
This analysis provides a current evidence-based estimate of PACG prevalence in European derived populations and suggests there are 130 000 people in the UK, 1.60 million people in Europe and 581 000 people in the USA with PACG today. Accounting for ageing population structures, cases are predicted to increase by 19% in the UK, 9% in Europe and 18% in the USA within the next decade. PACG is more common than previously thought, and all primary glaucoma cases should be considered to be PACG until the anterior chamber angle is shown to be open on gonioscopy.

Download full-text

Full-text

Available from: Alex C Day, Mar 01, 2015
2 Followers
 · 
193 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: This review has used systematic methodology to provide a robust list of devices relevant to 19 sub-conditions which are the cause of most morbidity and mortality to elderly people in the Western Pacific Region. A final list of needed devices will likely benefit from a consideration of other methods, including those of economic evaluation and social impact, input regarding clinical, policy, organizational and infrastructure issues, together with research contextualising the results to each country in the Western Pacific Region. It is intended that the output of this report will inform future research with the ultimate aim to improve access of needed devices to the elderly.
  • [Show abstract] [Hide abstract]
    ABSTRACT: PURPOSE: Recently, several studies have investigated genetic associations between Cytochrome P450 (CYP1B1), endothelial nitric oxide synthase (eNOS) and Neurotrophin-4 (NTF4) with primary angle closure glaucoma (PACG) in various ethnic groups. Here we investigate the association of these candidate genes with PACG in two different populations from Australia and Nepal. METHOD: A total of 306 patients with PACG (106 Nepalese and 200 Australian) and 492 controls (204 Nepalese and 288 Australian) were included in the current study. Tag single nucleotide polymorphisms (SNPs) were selected to cover the majority of common variation within the candidate genes and genotyped in DNA extracted from peripheral whole blood. Allele and haplotype analyses were conducted in PLINK. Bonferroni correction was applied for the total number of SNPs in this study (0.05/15=0.0033) RESULTS: In the Australian cohort, one eNOS SNP rs3793342 p=0.002 showed significant association with PACG after correction for multiple testing. The eNOS haplotype of all 7 typed SNPs showed significant association with a global p value of 0.01, with the CGCAATC haplotype giving a specific p-value of 0.0006 and odds ratio of 1.4 (95% CI 0.9-2.1). In the Nepalese cohort, SNPs in CYP1B1 and NTF4 genes showed borderline association with PACG but did not survive Bonferroni correction. CONCLUSIONS: The present data support the involvement of common variations in eNOS with PACG pathogenesis. Differences were observed in the two populations studied, and additional replication studies in other populations are necessary to confirm these associations.
    Investigative ophthalmology & visual science 02/2013; 54(3). DOI:10.1167/iovs.12-11391 · 3.66 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: A recent large genome-wide association study (GWAS) identified multiple variants associated with primary angle-closure glaucoma (PACG). The present study investigated the role of these variants in two cohorts with PACG recruited from Australia and Nepal. Patients with PACG and appropriate controls were recruited from eye clinics in Australia (n = 232 cases and n = 288 controls) and Nepal (n = 106 cases and 204 controls). Single nucleotide polymorphisms (SNPs) rs3753841 (COL11A1), rs1015213 (located between PCMTD1 and ST18), rs11024102 (PLEKHA7), and rs3788317 (TXNRD2) were selected and genotyped on the Sequenom. Analyses were conducted using PLINK and METAL. After adjustment for age and sex, SNP rs3753841 was found to be significantly associated with PACG in the Australian cohort (p = 0.017; OR = 1.34). SNPs rs1015213 (p = 0.014; OR 2.35) and rs11024102 (p = 0.039; OR 1.43) were significantly associated with the disease development in the Nepalese cohort. None of these SNPs survived Bonferroni correction (p = 0.05/4 = 0.013). However, in the combined analysis, of both cohorts, rs3753841 and rs1015213 showed significant association with p-values of 0.009 and 0.004, respectively both surviving Bonferroni correction. SNP rs11024102 showed suggestive association with PACG (p-value 0.035) and no association was found with rs3788317. The present results support the initial GWAS findings, and confirm the SNP's contribution to PACG. This is the first study to investigate these loci in both Australian Caucasian and Nepalese populations.
    PLoS ONE 06/2013; 8(6):e67903. DOI:10.1371/journal.pone.0067903 · 3.53 Impact Factor